APOE and atherosclerosis: In future studies, the human scFv-Fc antibodies will serve for in vivo experiments on atherosclerotic ApoE−/− mice as suitable moieties after grafting on nanoparticles for (i) a more accurate diagnosis of atherosclerosis dedicated to MRI imaging and (ii) the development of therapeutic strategies.